Is the mTOR‐signalling cascade disrupted in Schizophrenia?
Authors:
- 25 December 2013
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 129 (3) , 377-387
Abstract
The mammalian target of rapamycin (mTOR) signalling cascade is involved in the intracellular regulation of protein synthesis, specifically for proteins involved in controlling neuronal morphology and facilitating synaptic plasticity. Research has revealed that the activity of the mTOR cascade is influenced by several extracellular and environmental factors that have been implicated in schizophrenia. Therefore, there is reason to believe that one of the downstream consequences of dysfunction or hypofunction of these factors in schizophrenia is disrupted mTOR signalling and hence impaired protein synthesis. This results in abnormal neurodevelopment and deficient synaptic plasticity, outcomes which could underlie some of the positive, negative and cognitive symptoms of schizophrenia. This review will discuss the functional roles of the mTOR cascade and present evidence in support of a novel mTOR‐based hypothesis of the neuropathology of schizophrenia. image During neurodevelopment, genetic and epigenetic factors can disrupt mTOR signalling which affects synthesis of proteins essential for correct neuronal growth and network connectivity. This renders the CNS particularly vulnerable to the effects of secondary factors during adolescence which increases the risk of developing schizophrenia in adulthood. This review discusses the functional roles of the mTOR cascade and presents evidence in support of a novel mTOR‐based hypothesis of the neuropathology of schizophrenia. Testing this hypothesis will advance our understanding of the aetiology of this illness and reveal novel therapeutic targets.Keywords
Funding Information
- Australian National Health and Medical Research Council
This publication has 99 references indexed in Scilit:
- Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2Cell Metabolism, 2013
- Rethinking schizophrenia in the context of normal neurodevelopmentFrontiers in Cellular Neuroscience, 2013
- 5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophreniaEMBO Molecular Medicine, 2012
- DISC1-binding proteins in neural development, signalling and schizophreniaNeuropharmacology, 2012
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for TreatmentNeuropsychopharmacology, 2011
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1 -null miceProceedings of the National Academy of Sciences, 2008
- Substance abuse and schizophrenia: Pharmacotherapeutic interventionJournal of Substance Abuse Treatment, 2008
- Identification of Protor as a novel Rictor-binding component of mTOR complex-2Biochemical Journal, 2007
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature Cell Biology, 2003